{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:49:27Z","timestamp":1780436967849,"version":"3.54.1"},"reference-count":37,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T00:00:00Z","timestamp":1564876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dokkyo Medical University School of Medicine","award":["2016-01"],"award-info":[{"award-number":["2016-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Japanese encephalitis virus (JEV) is classified into five genotypes labelled I through V. Although the genotype V (GV) JEV was originally found and had apparently been limited in Malaysia for more than 50 years, its emergence in Korea and China has recently been reported. Therefore, the GV JEV might be spreading over new geographical regions as a cause of potential public health problems. However, it is unknown whether the currently available JEV vaccines are effective against the emerging GV strains. To investigate this issue, a novel virus-like particle-based neutralizing assay was developed in this study. By using this assay, the inactivated JEV vaccine used in Japan and the recombinant sub-viral particles (SVPs) bearing the E protein of the GV Muar strain were characterized for the immunogenicity against the GV JEV. Although the inactivated vaccine alone failed to elicit a detectable level of neutralizing antibodies against the GV JEV, the vaccine added with the Muar-derived SVPs induced relatively high titers of neutralizing antibodies, associated with the efficient Th1 immune responses, against the GV JEV. The results indicate that addition of the GV JEV-derived antigens may be useful for developing the vaccine that is universally effective against JEV including the emerging GV strains.<\/jats:p>","DOI":"10.3390\/vaccines7030081","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T03:25:22Z","timestamp":1564975522000},"page":"81","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effects of the Japanese Encephalitis Virus Genotype V-Derived Sub-Viral Particles on the Immunogenicity of the Vaccine Characterized by a Novel Virus-Like Particle-Based Assay"],"prefix":"10.3390","volume":"7","author":[{"given":"Sarah","family":"Honjo","sequence":"first","affiliation":[{"name":"Department of Microbiology, Dokkyo Medical University School of Medicine, 880 Kita-kobayashi, Mibu-machi, Shimotsuga-gun, Tochigi 321-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Dokkyo Medical University School of Medicine, 880 Kita-kobayashi, Mibu-machi, Shimotsuga-gun, Tochigi 321-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Dokkyo Medical University School of Medicine, 880 Kita-kobayashi, Mibu-machi, Shimotsuga-gun, Tochigi 321-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","article-title":"Japanese encephalitis","volume":"68","author":"Solomon","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_2","unstructured":"Knipe, D.M., and Howley, P.M. (2013). Flaviviruses. Fields Virology, Lippincott Williams & Wilkins. [6th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2217\/fvl.10.55","article-title":"Combating Japanese encephalitis: Vero-cell derived inactivated vaccines and the situation in Japan","volume":"5","author":"Ishikawa","year":"2010","journal-title":"Future Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.ento.54.110807.090510","article-title":"Ecology and geographical expansion of Japanese encephalitis virus","volume":"54","author":"Ritchie","year":"2009","journal-title":"Annu. Rev. Entomol."},{"key":"ref_5","unstructured":"Knipe, D.M., and Howley, P.M. (2013). Flaviviridae. Fields Virology, Lippincott Williams & Wilkins. [6th ed.]."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0264-410X(94)90294-1","article-title":"Comparison of structural proteins among antigenically different Japanese encephalitis virus strains","volume":"12","author":"Hasegawa","year":"1994","journal-title":"Vaccine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1517\/21678707.2014.934222","article-title":"Japanese encephalitis: Epidemiology, prevention and current status of antiviral drug development","volume":"2","author":"Ishikawa","year":"2014","journal-title":"Expert Opin. Orphan Drugs"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/JVI.77.5.3091-3098.2003","article-title":"Origin and evolution of Japanese encephalitis virus in southeast Asia","volume":"77","author":"Solomon","year":"2003","journal-title":"J. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.meegid.2011.01.020","article-title":"Molecular phylogenetic and evolutionary analyses of Muar strain of Japanese encephalitis virus reveal it is the missing fifth genotype","volume":"11","author":"Mohammed","year":"2011","journal-title":"Infect. Genet. Evol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Li, M.H., Fu, S.H., Chen, W.X., Wang, H.Y., Guo, Y.H., Liu, Q.Y., Li, Y.X., Luo, H.M., Da, W., and Duo Ji, D.Z. (2011). Genotype v Japanese encephalitis virus is emerging. PLoS Negl. Trop. Dis., 5.","DOI":"10.1371\/journal.pntd.0001231"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/1743-422X-8-449","article-title":"Emergence of Japanese encephalitis virus genotype V in the Republic of Korea","volume":"8","author":"Takhampunya","year":"2011","journal-title":"Virol. J."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kim, H., Cha, G.W., Jeong, Y.E., Lee, W.G., Chang, K.S., Roh, J.Y., Yang, S.C., Park, M.Y., Park, C., and Shin, E.H. (2015). Detection of Japanese encephalitis virus genotype V in Culex orientalis and Culex pipiens (Diptera: Culicidae) in Korea. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116547"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1128\/JVI.00358-15","article-title":"A Japanese encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: Impact of the structural protein region on virulence","volume":"89","author":"Frenkiel","year":"2015","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1099\/vir.0.000213","article-title":"In vitro growth, pathogenicity and serological characteristics of the Japanese encephalitis virus genotype V Muar strain","volume":"96","author":"Tajima","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.vaccine.2014.01.040","article-title":"A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available","volume":"32","author":"Ishikawa","year":"2014","journal-title":"Vaccine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/cid\/cis883","article-title":"Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes","volume":"56","author":"Erra","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.virusres.2014.10.010","article-title":"Construction of an infectious molecular clone of Japanese encephalitis virus genotype V and its derivative subgenomic replicon capable of expressing a foreign gene","volume":"195","author":"Ishikawa","year":"2015","journal-title":"Virus Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/cb3002478","article-title":"Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate","volume":"7","author":"Hall","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.vaccine.2008.03.010","article-title":"Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis","volume":"26","author":"Ishikawa","year":"2008","journal-title":"Vaccine"},{"key":"ref_20","unstructured":"Knipe, D.M., and Howley, P.M. (2001). The immune response to flaviviruses. Fields Virology, Lippincott-Raven Publisher. [4th ed.]."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jviromet.2009.05.016","article-title":"Establishment of a neutralization test involving reporter gene-expressing virus-like particles of tick-borne encephalitis virus","volume":"161","author":"Yoshii","year":"2009","journal-title":"J. Virol. Methods"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mercier-Delarue, S., Durier, C., de Verdiere, N.C., Poveda, J.D., Meiffredy, V., Garcia, M.D.F., Lastere, S., Cesaire, R., Manuggera, J.C., and Molina, J.M. (2017). Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177882"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Mattia, K., Puffer, B.A., Williams, K.L., Gonzalez, R., Murray, M., Sluzas, E., Pagano, D., Ajith, S., Bower, M., and Berdougo, E. (2011). Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027252"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e00834-17","DOI":"10.1128\/JVI.00834-17","article-title":"Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus","volume":"91","author":"Garg","year":"2017","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Cao, L., Fu, S., Gao, X., Li, M., Cui, S., Li, X., Cao, Y., Lei, W., Lu, Z., and He, Y. (2016). Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004686"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/viro.2001.1048","article-title":"Locus of a virus neutralization epitope on the Japanese encephalitis virus envelope protein determined by use of long PCR-based region-specific random mutagenesis","volume":"287","author":"Morita","year":"2001","journal-title":"Virology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/JVI.77.4.2600-2606.2003","article-title":"A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites","volume":"77","author":"Lin","year":"2003","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0042-6822(91)90034-9","article-title":"Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection","volume":"180","author":"Mason","year":"1991","journal-title":"Virology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection","volume":"1","author":"Pierson","year":"2007","journal-title":"Cell Host Microbe"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.141.10.3606","article-title":"Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies","volume":"141","author":"Yasui","year":"1988","journal-title":"J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15107","DOI":"10.1128\/JVI.79.24.15107-15113.2005","article-title":"Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus","volume":"79","author":"Aberle","year":"2005","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1084\/jem.165.1.64","article-title":"IgG2a restriction of murine antibodies elicited by viral infections","volume":"165","author":"Coutelier","year":"1987","journal-title":"J. Exp. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1099\/vir.0.067280-0","article-title":"A poorly neutralizing IgG2a\/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus","volume":"95","author":"Chen","year":"2014","journal-title":"J. Gen. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/08830185.2013.773326","article-title":"Particulate adjuvant and innate immunity: Past achievements, present findings, and future prospects","volume":"32","author":"Kuroda","year":"2013","journal-title":"Int. Rev. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/vaccines2020297","article-title":"Vaccine Potentiation by Combination Adjuvants","volume":"2","author":"Levast","year":"2014","journal-title":"Vaccines"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1099\/vir.0.18676-0","article-title":"T helper responses to Japanese encephalitis virus infection are dependent on the route of inoculation and the strain of mouse used","volume":"84","author":"Ramakrishna","year":"2003","journal-title":"J. Gen. Virol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/7\/3\/81\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:13:14Z","timestamp":1760188394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/7\/3\/81"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,4]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["vaccines7030081"],"URL":"https:\/\/doi.org\/10.3390\/vaccines7030081","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,4]]}}}